首页> 外文OA文献 >Dilution of molecular-pathologic gene signatures by medically associated factors might prevent prediction of resection status after debulking surgery in patients with advanced ovarian cancer.

【2h】

Dilution of molecular-pathologic gene signatures by medically associated factors might prevent prediction of resection status after debulking surgery in patients with advanced ovarian cancer.

机译：由医学相关因素稀释分子病理基因签名可能会阻止在晚期卵巢癌患者的患者患者手术后预测切除状态。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Florian Heitz; Stefan Kommoss; Roshan Tourani; Anthony Grandelis; Locke Uppendahl; Constantin Aliferis; Alexander Burges; Chen Wang; Ulrich Canzler; Jinhua Wang; Antje Belau; Sonia Prader; Lars Hanker; Sisi Ma; Beyhan Ataseven; Felix Hilpert; Stephanie Schneider; Jalid Sehouli; Rainer Kimmig; Christian Kurzeder; Barbara Schmalfeldt; Elena I. Braicu; Philipp Harter; Sean C. Dowdy; Boris J. Winterhoff; Jacobus Pfisterer; Andreas du Bois;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer [J] . Heitz Florian, Kommoss Stefan, Tourani Roshan, Clinical cancer research: an official journal of the American Association for Cancer Research . 2020,第1期

机译：通过医学相关因素稀释分子病理基因签名可能会阻止在晚期卵巢癌患者患者患者患者术后预测切除状态的预测
2. Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer [J] . Makar Amin P., Trope Claes G., Tummers Philippe, The oncologist . 2016,第6期

机译：晚期卵巢癌：原发性或间隔性减灭？从随机试验和肿瘤生物学的结果来看，五类患者是晚期卵巢癌的原发减瘤术和间隔减瘤术
3. Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer [J] . Amin P. Makar, Claes G. Trop??, Philippe Tummers, The oncologist . 2016,第6期

机译：晚期卵巢癌：原发性或间隔性减灭？从随机试验和肿瘤生物学的结果来看，五类患者是晚期卵巢癌的原发减瘤术和间隔减瘤术
4. Delta-Radiomics Signature For Prediction Of Survival In Advanced Nsclc Patients Treated With Immunotherapy [C] . B. Farina, A. D. Ramos Guerra, C. Palacios Miras, IEEE International Symposium on Biomedical Imaging . 2021

机译：用于预测免疫疗法治疗的高级NSCLC患者存活的三角洲 - 辐射瘤
5. Factors influencing hopelessness and complementary therapy use in patients with ovarian cancer. [D] . Gross, Anne H. 2010

机译：影响卵巢癌患者绝望和辅助治疗的因素。
6. Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer [O] . Amin P. Makar, Claes G. Tropé, Philippe Tummers, 2016

机译：晚期卵巢癌：原发性或间隔性减灭？从随机试验和肿瘤生物学的结果来看五类患者是晚期卵巢癌的原发减瘤术和间隔减瘤术
7. Advanced ovarian cancer: primary or interval debulking? : five categories of patients in view of the results of randomize trials and tumor biology : primary debulking surgery an interval debulking surgery for advanced ovarian cancer [O] . Makar, Amin, Tropé, Claes G, TUMMERS, PHILIPPE, 2016

机译：晚期卵巢癌：原发性或间隔性减瘤？：根据随机试验和肿瘤生物学的结果分为五类患者：原发性切除手术和晚期卵巢癌间隔减压手术

Dilution of molecular-pathologic gene signatures by medically associated factors might prevent prediction of resection status after debulking surgery in patients with advanced ovarian cancer.

著录项

相似文献

相关主题

期刊订阅